Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes.

[1]  Graham F. Brady,et al.  Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort , 2017, Clinical endocrinology.

[2]  A. Garg,et al.  Homozygous LIPE mutation in siblings with multiple symmetric lipomatosis, partial lipodystrophy, and myopathy , 2017, American journal of medical genetics. Part A.

[3]  D. Ory,et al.  Fatty acid synthesis configures the plasma membrane for inflammation in diabetes , 2016, Nature.

[4]  K. Alitalo,et al.  VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications. , 2016, Cell metabolism.

[5]  Jerrold M. Olefsky,et al.  Regulation of metabolism by the innate immune system , 2016, Nature Reviews Endocrinology.

[6]  T. Funahashi,et al.  Visualized macrophage dynamics and significance of S100A8 in obese fat , 2015, Proceedings of the National Academy of Sciences.

[7]  S. Kliewer,et al.  Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21 , 2015, Trends in Endocrinology & Metabolism.

[8]  R. Evans,et al.  A subcutaneous adipose tissue–liver signalling axis controls hepatic gluconeogenesis , 2015, Nature Communications.

[9]  John F. Robinson,et al.  A novel LIPE nonsense mutation found using exome sequencing in siblings with late-onset familial partial lipodystrophy. , 2014, The Canadian journal of cardiology.

[10]  M. Blüher,et al.  Evidence of Early Alterations in Adipose Tissue Biology and Function and Its Association With Obesity-Related Inflammation and Insulin Resistance in Children , 2014, Diabetes.

[11]  A. Tall,et al.  Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. , 2014, Cell metabolism.

[12]  A. Saltiel,et al.  Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKKε and TBK1 , 2013, eLife.

[13]  R. Frederich,et al.  Clinically relevant reductions in HbA1c without hypoglycaemia: results across four studies of saxagliptin , 2013, International journal of clinical practice.

[14]  B. Howard,et al.  Cardiovascular Characteristics in Subjects With Increasing Levels of Abnormal Glucose Regulation , 2013, Diabetes Care.

[15]  K. Clément,et al.  Roles of chemokine ligand-2 (CXCL2) and neutrophils in influencing endothelial cell function and inflammation of human adipose tissue. , 2013, Endocrinology.

[16]  I. Hochberg,et al.  An inhibitor of the protein kinases TBK1/IKKε improves obesity-related metabolic dysfunctions , 2013, Nature Medicine.

[17]  P. Trayhurn.  Hypoxia and adipose tissue function and dysfunction in obesity. , 2013, Physiological reviews.

[18]  David G Hendrickson,et al.  Differential analysis of gene regulation at transcript resolution with RNA-seq , 2012, Nature Biotechnology.

[19]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[20]  J. Rosenstock,et al.  Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes , 2012, Diabetes Care.

[21]  C. Glass,et al.  Inflammation and lipid signaling in the etiology of insulin resistance. , 2012, Cell metabolism.

[22]  J. Pollard,et al.  Dichotomous effects of VEGF-A on adipose tissue dysfunction , 2012, Proceedings of the National Academy of Sciences.

[23]  A. Chawla,et al.  Macrophage-mediated inflammation in metabolic disease , 2011, Nature Reviews Immunology.

[24]  Carey N Lumeng,et al.  Inflammatory links between obesity and metabolic disease. , 2011, The Journal of clinical investigation.

[25]  G. Willemsen,et al.  The heritability of beta cell function parameters in a mixed meal test design , 2011, Diabetologia.

[26]  E. Ravussin,et al.  The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance , 2010, Nature Medicine.

[27]  G. Hotamisligil,et al.  Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease , 2010, Cell.

[28]  L. Lau,et al.  Matricellular Protein CCN1 Activates a Proinflammatory Genetic Program in Murine Macrophages , 2010, The Journal of Immunology.

[29]  C. Glass,et al.  Macrophages, inflammation, and insulin resistance. , 2010, Annual review of physiology.

[30]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[31]  Nathan R. Qi,et al.  The Protein Kinase IKKɛ Regulates Energy Balance in Obese Mice , 2009, Cell.

[32]  C. Ersoy,et al.  Comparison of composite whole body insulin sensitivity index derived from mixed meal test and oral glucose tolerance test in insulin resistant obese subjects , 2009, Endocrine.

[33]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[34]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[35]  S. Reeder,et al.  Multiecho water‐fat separation and simultaneous R  2* estimation with multifrequency fat spectrum modeling , 2008, Magnetic resonance in medicine.

[36]  Judith Wylie-Rosett,et al.  Nutrition Recommendations and Interventions for Diabetes , 2008, Diabetes Care.

[37]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[38]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[39]  R. Leibel,et al.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.

[40]  A. Hevener,et al.  IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.

[41]  Kohjiro Ueki,et al.  Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[43]  M. White,et al.  SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2* , 2002, The Journal of Biological Chemistry.

[44]  J. Horowitz,et al.  Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women. , 2000, American journal of physiology. Endocrinology and metabolism.

[45]  S. Collins,et al.  Depressed expression of adipocyte β-adrenergic receptors is a common feature of congenital and diet-induced obesity in rodents , 1999, International Journal of Obesity.

[46]  P. Arner.  Catecholamine-induced lipolysis in obesity , 1999, International Journal of Obesity.

[47]  M. Baggiolini,et al.  HCC-2, a human chemokine: gene structure, expression pattern, and biological activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[48]  C. Pecqueur,et al.  In vivo resistance of lipolysis to epinephrine. A new feature of childhood onset obesity. , 1997, The Journal of clinical investigation.

[49]  B. Lowell,et al.  Brown adipose tissue, beta 3-adrenergic receptors, and obesity. , 1997, Annual review of medicine.

[50]  Lowell Bb,et al.  BROWN ADIPOSE TISSUE, β3-ADRENERGIC RECEPTORS, AND OBESITY , 1997 .

[51]  S. Reynisdottir,et al.  Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. , 1994, The Journal of clinical investigation.

[52]  T. Nakazawa,et al.  [Inhibitory effect of amlexanox on asthmatic attacks in an aspirin sensitive asthmatic]. , 1992, Nihon Kyobu Shikkan Gakkai zasshi.

[53]  C. Christiansen,et al.  Validation of body composition by dual energy X-ray absorptiometry (DEXA). , 1991, Clinical physiology.

[54]  K. Sasaki,et al.  Pharmacodynamics of Amlexanox (AA-673) in normal and anaphylactic rat conjunctiva and its effect on histamine concentration. , 1990, Ophthalmic research.

[55]  Y. Maki,et al.  Mechanism of action of an antiallergic agent, amlexanox (AA-673), in inhibiting histamine release from mast cells. Acceleration of cAMP generation and inhibition of phosphodiesterase. , 1987, International archives of allergy and applied immunology.

[56]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.